The effects of oxytocin on social cognition in schizophrenia

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Schizophrenia is characterised by problems with social cognition. These problems are associated with an increased risk of low educational attainment, unemployment, homelessness, social isolation, and reduced quality of life. This project will determine whether a novel biological intervention, Oxytocin, improves social interaction behaviour skills in schizophrenia. This project, therefore, represents a critical first step in developing a new treatment for schizophrenia.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2012

Funding Scheme: NHMRC Project Grants

Funding Amount: $187,631.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Health, Clinical and Counselling Psychology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Eye-gaze | Novel Therapeutic | Oxytocin (OT) | Psychiatry | Schizophrenia | Social cognition